Pharmaceutical firms stalling on new plans

Reflecting increasing uncertainty in the global economy with protracted weakening of the won against the U.S. dollar and the Japanese yen, major Korean pharmaceutical manufacturers are delaying the formulation of their business plans for next year.

The won has fallen more than 35 percent against the dollar this year, and about 18 percent since the beginning of September. Against the Japanes...